+46(0)8 400 112 30 contact@offspringbiosciences.com

Our team

Per Sunnemark

Chairman of the Board

Per Sunnemark is the CEO of Encare AB, a digital medtech company providing evidence based care systems. Mr Sunnemark has knowledge and experience from building and growing companies from startup environments as well as more established businesses within the IT/Software, Healthcare and HR sectors. He has held positions as CEO for Proffice Sweden, CEO of the listed healthcare company Feelgood, CEO of Paynova and CEO of Jobline and Monster Nordic operation. He holds a Master of Science from the Royal School of Technology in Stockholm.

Anders Dahlstrand

CEO and Director of Sales

Anders has over thirty-five years of work experience from conducting research in academic and pharmaceutical R&D settings. He was main responsible for driving the establishment, strategic directions and continuous development of an AstraZeneca internal unit which supported the internal R&D organisation with the type of histopathological analyses Offspring Biosciences now are offering to the wider scientific community. Anders has solid leadership and scientific skills acquired as academic research group leader and as team leader, project leader, department representative in project core teams and as member in line group management teams within the pharmaceutical industry.

Principal Scientist. AstraZeneca R&D, Södertälje, Sweden. 1998 – 2012
Assoc. Professor, Karolinska Institutet, Stockholm, Sweden, 2002 – now
Research group leader, Dept. of Medicine, The Karolinska Institute,
Stockholm, Sweden. 1994 – 1999
Postdoctoral fellow, The Salk Institute for Biological Studies, San Diego. 1991-1993
PhD. Karolinska Institutet, Stockholm, Sweden. 1987-1991
Phone: +46(0)73-202 0307


+46(0)73-202 0307
anders.dahlstrand@offspringbiosciences.com

Dan Sunnemark

Director of Operations and Project Management

Dan has over 30 years of experience working with techniques of direct relevance to our company’s service portfolio. He was main responsible for the establishment of a platform for histology-based target validation in neurology at AstraZeneca R&D, Södertälje. This included the build of a bank of animal and human tissues representing various neurological disorders as well as coordinating target validation studies from early pre-clinical phase to clinical trials in phase I. He has worked as department-representative in several drug development projects where he coordinated cross-functional activities across research and therapy areas, reporting to multiple customers and stakeholders. Dan has in-depth understanding of the drug development process in preclinical and early clinical phases and good knowledge of both small and large molecular drug pharmacology.

Associate Principal Scientist and Team leader, AstraZeneca R&D,
Södertälje, Sweden. 1999 – 2012
Postdoctoral fellow, Supervisor, Karolinska Institutet, Stockholm, Sweden. År 1998-1999
PhD, Immunology-Immunopathogenesis, Karolinska Institutet, Stockholm, Sweden. 1998

+46(0)70-816 1736
dan.sunnemark@offspringbiosciences.com

Anne Svensson

Laboratory Manager

Anne has over thirty years of working experience with techniques of direct relevance to the services offered by Offspring Biosciences. Mainly operative and lab-based responsibilities, including development, refinements and problem solving of scientific imaging technologies. Study planning, execution, interpretation and reporting. Delivering histology, immunohistochemistry, receptor autoradiography and in situ hybridization histochemistry-based analyses in local drug discovery projects.

Acting Team leader and Research Scientist, AstraZeneca R&D, Södertälje. 2003-2012
Biomedical Analyst at the Department of Clinical Immunology and Clinical Chemistry, Karolinska Institutet, Stockholm, Sweden 1976 -2002

+46(0)73-713 0902
anne.svensson@offspringbiosciences.com

Helen Jongsma Wallin

Senior Research Scientist

Helen has over 15 years of experience working with techniques relevant to the services offered by Offspring Biosciences. This includes solid skills from work in academic and pharmaceutical industry settings to develop, refine and apply technologies used to address questions in in vivo pharmacology and in vitro imaging studies. At Offspring, Helen is responsible as lead on some of our customer studies, from design/planning and execution to interpretation and reporting. At AstraZeneca, Helen functioned as department-representative in several drug development projects where she coordinated in vivo pharmacology activities and reported to multiple customers and stakeholders.

Senior Research Scientist, AstraZeneca R&D, Södertälje. 2003-2012
PhD, Neurobiology, Histology department, Lund University, Sweden, 2002

+46(0)70-759 2673
helen.jongsmawallin@offspringbiosciences.com

Mia Nilsson

Senior Research Scientist

Mia has over twenty years of working experience with techniques relevant to services offered by Offspring Biosciences. She has worked both in academia, pharmaceutical -, cosmetic - and biotech industry. At Offspring Biosciences Mia is responsible as a functional project leader from design/planning and execution to interpretation and reporting of different studies.
Research Scientist, Atlas Antibodies, Stockholm, 2017-2018
Sales in Histology, Histolab, Stockholm, 2016-2017
Senior Research Scientist, Offspring Biosciences, Södertälje, 2014-2016
Research Scientist, Oriflame Cosmetics, Stockholm, 2013-2014
Research Scientist, AstraZeneca, Södertälje, 1998-2012
Biomedical Analyst, Karolinska Institute, Solna, 1994-1998


+46 (0)73 683 89 10
mia.nilsson@offspringbiosciences.com